Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
/	O
Codeine	O
/	O
Shellfish	O
Derived	O
/	O
Bee	O
Pollens	O
/	O
kiwi	O
/	O
Avocado	O
/	O
carboplatin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
planned	O
admit	O
for	O
desensitization	O
to	O
chemotherapy	O
(carboplatin	O
hypersensitivity)	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms	O
___	O
is	O
a	O
___	O
yo	O
F	O
with	O
Stage	O
IIIC	O
papillary	O
serous	O
cancer	O
of	O
gynecologic	O
primary	O
treated	O
in	O
___	O
now	O
with	O
relapsed	O
disease,	O
presenting	O
for	O
C4D15	O
of	O
___	O
therapy	O
with	O
plan	O
for	O
desensitization,	O
due	O
to	O
carboplatin	O
hypersensitivity.	O
Had	O
history	O
of	O
platinum	O
sensitivity	O
during	O
first	O
occurunce	O
of	O
ovarian	O
cancer.	O
Initially	O
tolerated	O
carboplatinum	O
upon	O
restarting	O
wtih	O
recurrence	O
of	O
ovarian	O
cancer,	O
but	O
developed	O
itching/flushing	O
with	O
8th	O
dose.	O
She	O
was	O
premedicated	O
prior	O
to	O
9th	O
dose,	O
but	O
still	O
developed	O
similar	O
symptoms.	O
Refered	O
to	O
allergist,	O
seen	O
on	O
___	O
who	O
confirmed	O
carboplatin	O
allergy	O
by	O
skin	O
testing	O
and	O
recommended	O
inpatient	O
desensitization.	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
reports	O
feeling	O
very	O
anxious,	O
but	O
otherwise	O
well.	O
Took	O
___	O
and	O
AM	O
ceterizine	O
as	O
instructed.	O
Past	O
Medical	O
History:	O
-	O
On	O
___,	O
she	O
was	O
found	O
to	O
have	O
bilateral	O
adnexal	O
masses	O
on	O
pelvic	O
ultrasound,	O
which	O
was	O
being	O
done	O
on	O
an	O
annual	O
basis.	O
She	O
also	O
noticed	O
some	O
pelvic	O
pressure	O
or	O
discomfort	O
at	O
that	O
time.	O
-	O
3	O
cycles	O
of	O
neo-adjuvant	O
chemotherapy	O
with	O
___	O
Taxol	O
-	O
___:	O
resection	O
-	O
3	O
additional	O
cycles	O
of	O
weekly	O
taxol/carboplatin,	O
completed	O
___	O
-	O
Ct	O
scans	O
from	O
___	O
revealed	O
new	O
metastatic	O
implants	O
in	O
the	O
peritoneum.	O
-	O
___	O
C1D1	O
___	O
-	O
___:	O
C4D1	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Sister	O
w/	O
colon	O
CA	O
in	O
her	O
___,	O
diagnosed	O
early	O
and	O
now	O
in	O
good	O
health,	O
denies	O
hx	O
of	O
breast/gyn/pancreatic	O
CA	O
in	O
family,	O
paternal	O
grandfather	O
with	O
stomach	O
CA	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
(same	O
day	O
as	O
discharge)	O
VS:	O
97.7	O
101/65	O
89	O
18	O
100%	O
RA	O
GENERAL:	O
NAD	O
HEENT:	O
NC/AT,	O
EOMI,	O
PERRL,	O
MMM	O
CARDIAC:	O
RRR,	O
nl	O
S1	O
and	O
S2,	O
no	O
murmurs	O
LUNG:	O
CTAB	O
no	O
w/r/rh	O
ABD:	O
+BS,	O
soft,	O
NT/ND,	O
no	O
r/g	O
EXT:	O
No	O
lower	O
extremity	O
pitting	O
edema,	O
varicose	O
veins	O
NEURO:	O
CN	O
II-XII	O
intact.	O
SKIN:	O
Warm	O
and	O
dry	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
08:29AM	O
___	O
PTT-31.8	O
___	O
___	O
08:29AM	O
PLT	O
COUNT-277	O
___	O
08:29AM	O
WBC-4.0	O
RBC-3.25*	O
HGB-10.7*	O
HCT-31.1*	O
MCV-96	O
MCH-32.9*	O
MCHC-34.4	O
RDW-18.5*	O
___	O
08:29AM	O
ALBUMIN-4.0	O
CALCIUM-9.2	O
PHOSPHATE-4.0	O
MAGNESIUM-2.2	O
___	O
08:29AM	O
ALT(SGPT)-40	O
AST(SGOT)-37	O
TOT	O
BILI-0.2	O
___	O
08:29AM	O
GLUCOSE-95	O
UREA	O
N-14	O
CREAT-0.9	O
SODIUM-142	O
POTASSIUM-4.0	O
CHLORIDE-105	O
TOTAL	O
CO2-28	O
ANION	O
GAP-13	O
Brief	O
Hospital	O
Course:	O
Ms	O
___	O
is	O
a	O
___	O
yo	O
F	O
with	O
Stage	O
IIIC	O
papillary	O
serous	O
cancer	O
of	O
gynecologic	O
primary	O
treated	O
in	O
___	O
now	O
with	O
relapsed	O
disease,	O
presenting	O
for	O
C4D8	O
of	O
___	O
therapy	O
with	O
plan	O
for	O
desensitization,	O
due	O
to	O
carboplatin	O
hypersensitivity.	O
ACUTE	O
ISSUES:	O
#	O
Platinum	O
Hypersensitity:	O
Admitted	O
for	O
desensitization	O
to	O
carboplatin	O
after	O
prior	O
hypersensitivity	O
rxn	O
(see	O
H&P	O
for	O
more	O
details).	O
She	O
was	O
given	O
ceterizine	O
1hr	O
prior	O
to	O
inititiating	O
carboplatin	O
and	O
benadryl	O
and	O
famotidine	O
30	O
min	O
prior	O
to	O
initiating	O
carboplatin.	O
She	O
then	O
recieved	O
recieve	O
100	O
fold	O
and	O
10	O
fold	O
dilution	O
of	O
carboplatin	O
with	O
monitoring	O
prior	O
to	O
recieving	O
actual	O
dose	O
of	O
carboplatin	O
as	O
part	O
of	O
desensitization	O
protocol.	O
During	O
infusion	O
of	O
the	O
full	O
dose	O
carboplatin	O
she	O
did	O
develop	O
a	O
maculopapular	O
rash	O
over	O
her	O
trunk.	O
She	O
was	O
given	O
IV	O
benadryl	O
with	O
resolution	O
of	O
rash	O
and	O
remained	O
asymptomatic	O
during	O
the	O
remaineder	O
of	O
the	O
infusion.	O
CHRONIC	O
ISSUES:	O
#	O
Ovarian	O
Cancer:	O
C4D15	O
___	O
as	O
above;	O
got	O
gemcitabine	O
after	O
completing	O
carboplatin	O
infusions.	O
#	O
Overactive	O
bladder:	O
continued	O
home	O
Myrbetriq.	O
#	O
HLD:	O
continued	O
home	O
simvastatin.	O
#	O
Anxiety:	O
continued	O
home	O
sertraline.	O
TRANSITIONAL	O
ISSUE:	O
-	O
further	O
chemo	O
doses	O
to	O
be	O
determined	O
by	O
Dr	O
___	O
is	O
discussion	O
that	O
this	O
may	O
be	O
last	O
dose).	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
2.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q8H:PRN	O
N/V	O
3.	O
ALPRAZolam	O
0.25	O
mg	O
PO	O
BID:PRN	O
anxiety	O
4.	O
Rosuvastatin	O
Calcium	O
20	O
mg	O
PO	O
QPM	O
5.	O
Sertraline	O
150	O
mg	O
PO	O
DAILY	O
6.	O
Myrbetriq	O
(mirabegron)	O
25	O
mg	O
oral	O
DAILY	O
Discharge	O
Medications:	O
1.	O
ALPRAZolam	O
0.25	O
mg	O
PO	O
BID:PRN	O
anxiety	O
2.	O
Myrbetriq	O
(mirabegron)	O
25	O
mg	O
oral	O
DAILY	O
3.	O
Rosuvastatin	O
Calcium	O
20	O
mg	O
PO	O
QPM	O
4.	O
Sertraline	O
150	O
mg	O
PO	O
DAILY	O
5.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
6.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q8H:PRN	O
N/V	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary:	O
carboplatin	O
hypersensitivity,	O
ovarian	O
cancer	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
the	O
___	O
___.	O
You	O
were	O
admitted	O
for	O
desensitization	O
therapy	O
to	O
carboplatin	O
given	O
prior	O
allergy.	O
You	O
tolerated	O
this	O
process	O
well	O
and	O
recieved	O
cycle	O
4,	O
day	O
8	O
of	O
your	O
carboplatin/gemcitabine	O
therapy	O
for	O
ovarian	O
cancer.	O
Followup	O
Instructions:	O
___	O

